Page last updated: 2024-10-26

dilazep and Heart Failure

dilazep has been researched along with Heart Failure in 1 studies

Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pollter, J1
Schnitker, J1

Trials

1 trial available for dilazep and Heart Failure

ArticleYear
[Therapy of coronary heart disease using Cormelian-Digotab: influence of the duration of therapy. 2. Field study by 107 physicians].
    Die Medizinische Welt, 1976, Oct-22, Volume: 27, Issue:43

    Topics: Azepines; Clinical Trials as Topic; Coronary Disease; Digoxin; Dilazep; Drug Combinations; Heart Fai

1976